Oncolytics Biotech Inc.
ONCY
|
$1.06
-7.02%
-9.62%
330K
|
Health Technology
(0.0% 1d) (5.8% 1m) (-1.8% 1y) (0.0% 2d) (1.9% 3d) (1.9% 7d) (NaN% volume)
Earnings Calendar: 2023-11-03
Market Cap: $ 79,944,954
http://www.oncolyticsbiotech.com
Sec Filling | Patents | 23 employees
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
pathogens treatment
add to watch list Paper trade email alert is off
Press-releases
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: 0.0%
biotech fda breast cancer for meeting trial submission
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-07 (Crawled : 21:00) - prnewswire.com
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: 2.88%
H: 4.67%
C: -1.87%
biotech year financial results
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Published: 2024-03-05 (Crawled : 12:00) - prnewswire.com
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: 6.52%
H: 6.12%
C: 5.1%
biotech cancer pancreatic
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: -0.74%
H: 0.74%
C: -8.15%
biotech
Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
Published: 2023-12-07 (Crawled : 18:00) - biospace.com/
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: 2.92%
H: 0.0%
C: -0.71%
biotech positive sabcs
Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Published: 2023-11-03 (Crawled : 16:00) - prnewswire.com
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech positive
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-03 (Crawled : 11:00) - prnewswire.com
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech financial results
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: 0.65%
H: 9.94%
C: 8.33%
positive cancer pancreatic study
Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: 0.65%
H: 9.94%
C: 8.33%
success cancer study
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
Published: 2023-10-20 (Crawled : 14:30) - prnewswire.com
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
ONCY | $1.06 -7.02% -9.62% 330K
|
Health Technology
|
| O: -1.85%
H: 3.14%
C: -2.52%
MYGN F | $19.17 -1.94% -1.88% 680K
|
Health Technology
|
| O: 0.41%
H: 3.13%
C: 2.38%
ILMN | $121.16 -4.65% -4.86% 1.2M
|
Health Technology
|
| O: 0.02%
H: 0.94%
C: -0.3%
BNTX | $87.89 1.63% 1.59% 6.2K
|
Health Technology
|
| O: -1.46%
H: 0.48%
C: -1.06%
companies biotech cancer pancreatic treatment research
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 45% | 55% |
Top 10 Gainers
BRTX | $1.32 -1.49% 20.71% 3.3M
|
Professional, Scientific, and T...
PTN | $1.82 -5.21% 15.38% 290K
|
Health Technology
VIAO | $0.308 -26.67% 12.01% 390K
|
Electronic Technology
HNRA | $2.36 -9.58% 11.86% 220K
|
n/a
HYLN 4 | $1.32 -7.04% 8.33% 800K
|
Producer Manufacturing
UMAC | $1.85 -2.12% 8.11% 6.1K
|
AMX | $18.02 -0.17% 7.32% 580
|
Communications
BQ | $0.2429 -6.07% 6.63% 15
|
Consumer Non-Durables
GORO F | $0.534 -0.6% 6.55% 630K
|
Non-Energy Minerals
LBRT 4 | $22.1 -1.6% 6.29% 2.1M
|
Industrial Services
Last 48 Hours Insiders Buying
RMCF | $3.6492 2.51% -7.2% 7.1K
|
Consumer Non-Durables
|
20:10